Cedric "Jamie" Rutland, MD - An Animated Exploration of Chronic Fibrosing Interstitial Lung Disease: From Diagnosis to Management in the Era of Antifibrotic Therapy

33:27
 
Share
 

Manage episode 295711662 series 103624
By PeerView Press, 24 West 40th Street, Suite 950, New York, NY 10018, PVI, and PeerView Institute for Medical Education. Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio is streamed directly from their servers. Hit the Subscribe button to track updates in Player FM, or paste the feed URL into other podcast apps.
Go online to PeerView.com/QXS860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in interstitial lung disease discusses the diagnosis of and novel and emerging therapies to treat chronic fibrosing interstitial lung disease. Upon completion of this accredited CE activity, participants should be better able to: Recognize risk factors associated with the development of chronic fibrosing interstitial lung disease (CF-ILD), such as having a connective tissue disease, chronic hypersensitivity pneumonitis, and unclassifiable ILD, Identify signs and symptoms indicative of CF-ILD to allow for earlier diagnosis, pulmonary monitoring, and treatment, Discuss the latest clinical data on efficacy and safety for novel and emerging therapies to treat CF-ILD, Develop individualized treatment plans for patients with CF-ILD based on the latest expert recommendations and clinical evidence.

301 episodes